- Home
- MSM vs CRNX Comparison
MSM vs CRNX Comparison
Compare MSM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- CRNX
- Stock Information
- Founded
- MSM 1941
- CRNX 2008
- Country
- MSM United States
- CRNX United States
- Employees
- MSM N/A
- CRNX N/A
- Industry
- MSM Industrial Machinery/Components
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- CRNX Health Care
- Exchange
- MSM Nasdaq
- CRNX Nasdaq
- Market Cap
- MSM 5.1B
- CRNX 2.8B
- IPO Year
- MSM 1995
- CRNX 2018
- Fundamental
- Price
- MSM $91.25
- CRNX $34.20
- Analyst Decision
- MSM Hold
- CRNX Strong Buy
- Analyst Count
- MSM 5
- CRNX 7
- Target Price
- MSM $90.60
- CRNX $74.33
- AVG Volume (30 Days)
- MSM 440.8K
- CRNX 1.1M
- Earning Date
- MSM 10-23-2025
- CRNX 11-11-2025
- Dividend Yield
- MSM 3.73%
- CRNX N/A
- EPS Growth
- MSM N/A
- CRNX N/A
- EPS
- MSM 3.54
- CRNX N/A
- Revenue
- MSM $3,743,630,000.00
- CRNX $1,392,000.00
- Revenue This Year
- MSM N/A
- CRNX $489.51
- Revenue Next Year
- MSM $4.38
- CRNX $661.93
- P/E Ratio
- MSM $25.75
- CRNX N/A
- Revenue Growth
- MSM N/A
- CRNX 0.51
- 52 Week Low
- MSM $68.10
- CRNX $24.10
- 52 Week High
- MSM $94.31
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- MSM 54.46
- CRNX 58.12
- Support Level
- MSM $90.67
- CRNX $33.42
- Resistance Level
- MSM $92.76
- CRNX $37.23
- Average True Range (ATR)
- MSM 1.79
- CRNX 1.48
- MACD
- MSM -0.13
- CRNX -0.01
- Stochastic Oscillator
- MSM 47.51
- CRNX 56.59
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.